News for Ildong Pharmaceutical Co., Ltd. (249420.KS)

Published at

Apr 29, 2024 7:00 PM

by globenewswire.com

mixed

mixed

Cluster Headache Market is Anticipated to Showcase Immense Growth by 2032, Predicts DelveInsight | Key Companies - Lundbeck Seattle Biopharmaceuticals, Clexio Biosciences

The dynamics of the cluster headache market are anticipated to change during the forecast period (2023–2032) owing to the rising prevalence of cluster...

XLRN TORNTPHARM.NS TORNTPHARM.BO SHPMY SHPMF LLY.MX LLY.DE LLY.BA LLY LILY34.SA IONS.MX IONS INSM HLUYY HLUKF GOSS 2607.HK 249420.KS 0Q1G.L 0JDI.L 0JAV.L UTHR OCUL LQDA

Read more →
Published at

Apr 9, 2024 7:00 PM

by globenewswire.com

mixed

mixed

Treatment-Resistant Hypertension Market is Anticipated to Showcase Immense Growth by 2032, Predicts DelveInsight | Key Companies - Idorsia, Janssen Biotech, Quantum Genomics, CinCor Pharma, Ionis Phar

DelveInsight analysts project a favorable treatment-resistant hypertension market expansion, primarily driven by a rise in prevalence and the expected...

XLRN TORNTPHARM.NS TORNTPHARM.BO SHPMY SHPMF INSM IDRSF IDIA.SW GOSS AADI 2607.HK 249420.KS 0RQE.L 0JAV.L UTHR OCUL LQDA

Read more →
Published at

Nov 22, 2023 7:00 PM

by globenewswire.com

mixed

mixed

Ocular Hypertension Market Size and Share to Increase by 2032, Asserts DelveInsight | Leading Companies in the Market- Nicox, Glaukos, AbbVie, TearClear, Ocular, Perfuse

Several approved therapies such as EYBELIS, Durysta, Alphagan-P, Rhopressa, etc. will drive the current therapeutic landscape of ocular hypertension in the...

XLRN TORNTPHARM.NS TORNTPHARM.BO SPARC.NS SHPMY SHPMF OCUL INSM GOSS GKOS AADI 4576.T 2607.HK 249420.KS 0JAV.L UTHR LQDA

Read more →
Published at

Jul 19, 2023 11:01 PM

by prnewswire.com

mixed

mixed

Hypertension Market to Accelerate Positively, Estimates DelveInsight | Key Companies Active in the Market - Novartis, Bayer, Merck, Insmed, Acceleron, AbbVie, Alnylam, Apnimed, AstraZeneca, Gossamer B

/PRNewswire/ -- DelveInsight's Hypertension Market Insights report includes a comprehensive understanding of current treatment practices, hypertension emerging...

XLRN TORNTPHARM.NS TORNTPHARM.BO SHPMY SHPMF INSM GOSS AADI 2607.HK 249420.KS 0JAV.L UTHR OCUL LQDA

Read more →
Published at

Oct 3, 2022 7:00 PM

by globenewswire.com

mixed

mixed

Hypertension Clinical Trials Pipeline Analysis: 90+ Companies are Working to Improve the Treatment Space | DelveInsight

As per a statement of World Health Organization (WHO), Hypertension is one of the silent killers in 21st century and is one of the biggest global public...

XLRN UTHR LQDA IDRSF IDIA.SW 0RQE.L TORNTPHARM.NS TORNTPHARM.BO SHPMY SHPMF OCUL INSM GOSS 2607.HK 249420.KS 0JAV.L

Read more →
Published at

Jul 17, 2022 7:08 AM

by etfdailynews.com

positive

positive

Comparing PepGen (NASDAQ:PEPG) and TG Therapeutics (NASDAQ:TGTX)

Read Comparing PepGen (NASDAQ:PEPG) and TG Therapeutics (NASDAQ:TGTX) at ETF Daily News

TGTX LGND CKPT 249420.KS 0VGI.L

Read more →
Published at

Jul 14, 2022 9:58 AM

by prnewswire.com

neutral

neutral

Skin Microbiome Market Will Touch Promising Growth of USD 1950.38 million with CAGR of 13.68% during the forecast period 2022 to 2029| Size, Growth, Key Players, Demand and Opportunity

/PRNewswire/ -- Data Bridge Market Research has recently published the comprehensive business research on "Global Skin Microbiome Market" includes historic...

249420.KS

Read more →
Published at

Jul 10, 2022 7:44 AM

by etfdailynews.com

positive

positive

Contrasting Galapagos (NASDAQ:GLPG) and TG Therapeutics (NASDAQ:TGTX)

Read Contrasting Galapagos (NASDAQ:GLPG) and TG Therapeutics (NASDAQ:TGTX) at ETF Daily News

TGTX LGND GXE.DE GLPGF GLPG.AS GLPG GIS.DE GILDD.BA GILD.MX GILD CKPT 249420.KS 0VGI.L

Read more →